When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Acne vulgar

Última revisão: 27 Feb 2025
Última atualização: 23 Jan 2025

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • lesões cutâneas
Detalhes completos

Outros fatores diagnósticos

  • sensibilidade cutânea
  • queixas sistêmicas
Detalhes completos

Fatores de risco

  • adolescência ou adultos jovens
  • predisposição genética
  • pele oleosa/produção de sebo aumentada
  • uso de determinados medicamentos
  • uso de terapia com hormônio masculinizante
  • endocrinopatias
  • fatores alimentares
  • sexo feminino
  • obesidade/resistência insulínica
  • exposição a hidrocarbonetos aromáticos halogenados
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • diagnóstico clínico
Detalhes completos

Investigações a serem consideradas

  • avaliação hormonal
  • cultura bacteriana
Detalhes completos

Algoritmo de tratamento

CONTÍNUA

acne leve: não gestante

acne moderada a grave ou acne resistente ao tratamento padrão: não gestante

gestante

Colaboradores

Autores

Robert P. Dellavalle, MD, PhD, MSPH

Professor of Dermatology and Public Health

University of Minnesota Dermatology Department

National Dermatology Program Director

US Department of Veterans Affairs

Minneapolis

MN

Declarações

RPD has received editorial stipends (Journal of Medical Internet Research Dermatology (JMIR Dermatology)), royalties (UpToDate), and expenses reimbursement (Cochrane). RPD is an editor-in-chief of JMIR Dermatology, a joint coordinating editor for Cochrane Skin, a dermatology section editor for UpToDate, a social media editor for JAAD, and a coordinating editor representative on the Cochrane Council. He is a Cochrane Council Co-Chair, and serves as the National Dermatology Program Director for the US Department of Veteran Affairs.

Torunn E. Sivesind, MD

Dermatology Resident Physician

University of Colorado Anschutz School of Medicine

Aurora

CO

Declarações

TES previously received fellowship funding from Pfizer and the National Institute of Health; TES previously served as an editorial board member-at-large for the Journal of Medical Internet Research Dermatology.

Agradecimentos

Professor Dellavalle and Dr Sivesind would like to gratefully acknowledge Dr Madeline Adelman, Dr Romerio Rodriguez, Dr Sarah Shangraw, Dr Mark Naftanel, Dr Yolanda Rosi Helfrich, and Dr Amanda Howland, previous contributors to this topic. The authors would like to thank Dr John Barbieri for his review of the topic. JB has received consulting fees from Dexcel Pharma.

Declarações

SS, MN, YRH, and AH declare that they have no competing interests. MA has received fellowship funding from the Pfizer Global Medical Grant, RR receives fellowship funding from the National Institute of Health.

Revisores

Gina Taylor, MD

Resident

Department of Dermatology

SUNY Downstate Medical Center

New York

NY

Declarações

GT declares that she has no competing interests.

Gillian Murphy, MD, FRCPI, FRCP, Edin

Consultant Dermatologist

Dermatology

Beaumont Hospital

Dublin

Ireland

Declarações

Not disclosed.

  • Acne vulgar images
  • Diagnósticos diferenciais

    • Acne queloidiana da nuca
    • Erupções acneiformes
    • Cloracne
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Guidelines of care for the management of acne vulgaris
    • Acne vulgaris: management
    Mais Diretrizes
  • Folhetos informativos para os pacientes

    Acne

    Mais Folhetos informativos para os pacientes
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal